Status:
RECRUITING
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
Lead Sponsor:
Desmond Tutu TB Centre
Collaborating Sponsors:
European Union
Conditions:
Respiratory Tract Infections (RTI)
Mucosal Immunity
Eligibility:
All Genders
Up to 13 years
Brief Summary
The goal of this observational study is to answer a few questions about respiratory tract infections in South African children: 1. How do children with COVID-19 and other respiratory (chest, throat, ...
Detailed Description
This observational cohort study will include children aged 0-13 years with acute respiratory tract infections who present to Tygerberg Hospital (TBH) for routine care. Key routine care data, including...
Eligibility Criteria
Inclusion
- \- Children aged 0-13 years with acute respiratory tract infections presenting to Tygerberg Hospital (TBH) in Cape Town, South Africa, for routine care
Exclusion
- Admitted for \< 72 hours
Key Trial Info
Start Date :
October 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06902194
Start Date
October 23 2024
End Date
November 1 2025
Last Update
March 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Desmond Tutu TB Centre, Tygerberg Hospital
Cape Town, Western Cape, South Africa, 7505
2
Desmond Tutu TB Centre
Cape Town, Western Cape, South Africa, 7505